Clinical Trial Update: Efficacy of Weekly Rifapentine and Isoniazid for Tuberculosis Prevention [Phase 3]

View source ↗

Summary

Phase 3 trial update on weekly rifapentine and isoniazid for prevention of tuberculosis in silicosis and tuberculosis conditions.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Silicosis
• Tuberculosis

Drugs mentioned

• rifapentine + isoniazid (rifapentine; isoniazid)

Snippet

Sponsor: Huashan Hospital | Conditions: Silicosis, Tuberculosis | Phase 3 | Status: COMPLETED